Income Statement

PHATHOM PHARMACEUTICALS, INC.

PHAT
Annual
Performance Overview Click any row in the table to add it to this chart
in millions USD
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Revenue
175.11 55.30 0.70 - - - -
Cost of Revenue
22.60 7.97 0.17 - - - -
Gross Profit
152.51 47.28 0.52 - - - -
Operating Expenses
312.50 324.75 167.83 172.44 135.08 125.67 106.22
Research & Development
32.78 34.08 49.90 71.44 72.34 98.15 20.37
Selling, General & Administrative
279.72 290.66 117.93 101.00 62.74 27.52 6.94
Other Operating Expenses
- - - - - - -
Operating Income
-159.99 -277.47 -167.31 -172.44 -135.08 -125.67 -106.22
Non-Operating Income
-61.26 -56.86 -34.28 -25.28 -8.80 -3.40 -148.92
Interest Income
7.04 15.16 7.88 2.13 0.04 1.09 1.09
Interest Expense
29.00 23.20 41.97 27.31 6.80 4.60 4.18
Other Non-Op Income / Expense
-0.19 -0.01 -0.19 -0.11 -2.06 -0.01 -0.01
Income Before Tax
-221.25 - - - - - -
Income Tax Expense
- - - - - - -
Non-Controlling Interest
- - - - - - -
Net Income
-221.25 -334.33 -201.59 -197.72 -143.88 -129.07 -255.13
Supplemental Per share data, derived & other items — not part of the income statement
in millions USD unless noted
Metric Dec 31, 2025 2025 FY Dec 31, 2024 2024 FY Dec 31, 2023 2023 FY Dec 31, 2022 2022 FY Dec 31, 2021 2021 FY Dec 31, 2020 2020 FY Dec 31, 2019 2019 FY
Depreciation & Amortization
- - - - - - -
EBITDA
-159.35 -276.67 -166.74 -171.82 -134.56 -125.34 -106.21
Earnings Per Share (Basic)
-3.03 -5.29 -3.93 -5.05 - - -
Diluted EPS
-3.03 -5.29 -3.93 -5.05 - - -
Weighted Average Shares
72.92 63.18 51.29 39.12 - - -
Diluted Weighted Avg Shares
72.92 63.18 51.29 39.12 - - -
Comprehensive Income
- - - - - - -